SCHEMBL2889557

SCHEMBL2889557

Nc1nc(Cl)cc(Nc2ccc(Nc3ccnc4[nH]ccc34)cc2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 12/20 0.63
MAPT P10636 2/20 0.50
POLA1 P09884 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CYP3A4 P08684 4/20 0.46
KMT2A Q03164 1/20 0.44
AXL P30530 2/20 0.44
CDC7 O00311 2/20 0.44
DAPK3 O43293 2/20 0.44
PRKACA P17612 2/20 0.44
CDK8 P49336 2/20 0.44
CDK7 P50613 2/20 0.44
PRKX P51817 2/20 0.44
ROCK1 Q13464 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
ALK Q9UM73 2/20 0.44
CHEK1 O14757 1/20 0.44
AURKA O14965 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2889735 0.90 ROCK2 (0.61) ROCK2MAPTPOLA1POLBGAA
SCHEMBL2881832 0.88 ROCK2 (0.69) ROCK2MAPTPOLA1POLBGAA
SCHEMBL4406963 0.87 ROCK2 (0.65) ROCK2MAPTPOLA1POLBGAA
SCHEMBL2888351 0.78 ROCK2 (0.67) ROCK2MAPTPOLA1POLBGAA
SCHEMBL2877122 0.78 ROCK2 (1.00) ROCK2CYP3A4AXLCDC7DAPK3
SCHEMBL858840 0.78 TTBK1 (0.59) MAPTGAAKMT2AAXLROCK1
SCHEMBL2881534 0.78 TTBK1 (0.54) AXLROCK1AURKAAURKBTNNI3K
SCHEMBL2881172 0.76 ROCK2 (0.80) ROCK2CYP3A4AXLCDC7DAPK3
SCHEMBL2887470 0.76 ROCK2 (0.65) ROCK2MAPTPOLA1POLBGAA
SCHEMBL4416215 0.76 ROCK2 (0.65) ROCK2MAPTPOLA1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723347-B2 Substituted phenylamino-pyrimidines BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-05-25 US disclosed
US-7723347-B2 Substituted phenylamino-pyrimidines BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-05-25 US disclosed
US-7723347-B2 Substituted phenylamino-pyrimidines BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-05-25 US disclosed
EP-1742945-B1 SUBSTITUTED PHENYLAMINO-PYRIMIDINES BAYER SCHERING PHARMA AG (DE) 2009-12-30 EP disclosed
US-20080269268-A1 Substituted Phenylamino-Pyrimidines BAYER HEALTHCARE AG (DE) 2008-10-30 US disclosed
US-20080269268-A1 Substituted Phenylamino-Pyrimidines BAYER HEALTHCARE AG (DE) 2008-10-30 US disclosed
US-20080269268-A1 Substituted Phenylamino-Pyrimidines BAYER HEALTHCARE AG (DE) 2008-10-30 US disclosed
EP-1742945-A1 SUBSTITUTED PHENYLAMINO-PYRIMIDINES Bayer HealthCare AG (DE) 2007-01-17 EP disclosed
WO-2005108397-A1 SUBSTITUTED PHENYLAMINO-PYRIMIDINES BAYER HEALTHCARE AG (DE) 2005-11-17 WO disclosed
WO-2005108397-A1 SUBSTITUTED PHENYLAMINO-PYRIMIDINES BAYER HEALTHCARE AG (DE) 2005-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269268-A1 Substituted Phenylamino-Pyrimidines TYMP, DPYD, HPRT1 ROCK2 4593/4885MAPT 3319/4885POLA1 305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.